Leukemia - Table of Contents alert Volume 23 Issue n1

TABLE OF CONTENTS Volume 23, Issue 1 (January 2009) In this issue Editorial Spotlight Reviews Reviews Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Cell Death & Differentiation presents the first Special Issue of 2009: Autophagy in Aging, Disease and Death: the True Identity of a Cell Death Impostor In this issue, prominent scientists review the basic physiology of autophagy, as a well as its implications for health and disease, in infection, immune responses, cancer, a range of organ-specific pathologies, and in age-related disorders. The complete Special Issue Autophagy in Aging, Disease and Death: the True Identity of a Cell Death Imposter is available online.   Why Publish in Leukemia? Efficient peer-review, hassle-free submission, recognition... Papers benefit from wide readership through hosting on nature.com and inclusion in the leading abstracting and indexing services. Rapid publication is also assured through Advance Online Publication. To read the full Guide to Authors for Leukemia, visit www.nature.com/leu/for_authors.html   Editorial Top The NIH consensus criteria for chronic graft-versus-host disease: far more than just another classification G Socié Leukemia 2009 23: 1-2; 10.1038/leu.2008.277 Abstract | Full Text Spotlight Reviews Top Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma R A Kyle & S V Rajkumar Leukemia 2009 23: 3-9; advance online publication, October 30, 2008; 10.1038/leu.2008.291 Abstract | Full Text Bone marrow microenvironment and the identification of new targets for myeloma therapy K Podar, D Chauhan & K C Anderson Leukemia 2009 23: 10-24; advance online publication, October 9, 2008; 10.1038/leu.2008.259 Abstract | Full Text Reviews Top Targeting the leukemic stem cell: the Holy Grail of leukemia therapy N Misaghian, G Ligresti, L S Steelman, F E Bertrand, J Bäsecke, M Libra, F Nicoletti, F Stivala, M Milella, A Tafuri, M Cervello, A M Martelli & J A McCubrey Leukemia 2009 23: 25-42; advance online publication, September 18, 2008; 10.1038/leu.2008.246 Abstract | Full Text CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers J A Burger & A Peled Leukemia 2009 23: 43-52; advance online publication, November 6, 2008; 10.1038/leu.2008.299 Abstract | Full Text Does chemotherapy modify the immune surveillance of hematological malignancies? A J Barrett & B N Savani Leukemia 2009 23: 53-58; advance online publication, October 2, 2008; 10.1038/leu.2008.273 Abstract | Full Text Original Articles Top Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species E Ortiz-Sánchez, T R Daniels, G Helguera, O Martinez-Maza, B Bonavida, & M L Penichet Leukemia 2009 23: 59-70; advance online publication, October 23, 2008; 10.1038/leu.2008.270 Abstract | Full Text A bispecific single-chain antibody that mediates target cell-restricted, supra-agonistic CD28 stimulation and killing of lymphoma cells T Otz, L Groe-Hovest, M Hofmann, H-G Rammensee & G Jung Leukemia 2009 23: 71-77; advance online publication, October 2, 2008; 10.1038/leu.2008.271 Abstract | Full Text Feasibility of NIH consensus criteria for chronic graft-versus-host disease B-S Cho, C-K Min, K-S Eom, Y-J Kim, H-J Kim, S Lee, S-G Cho, D-W Kim, J-W Lee, W-S Min & C-C Kim Leukemia 2009 23: 78-84; advance online publication, October 2, 2008; 10.1038/leu.2008.276 Abstract | Full Text Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked cases A Murati, C Gervais, N Carbuccia, P Finetti, N Cervera, J Adélaïde, S Struski, E Lippert, F Mugneret, I Tigaud, D Penther, C Bastard, B Poppe, F Speleman, L Baranger, I Luquet, P Cornillet-Lefebvre, N Nadal, F Nguyen-Khac, C Pérot, S Olschwang, F Bertucci, M Chaffanet, M Lessard, M-J Mozziconacci & D Birnbaum Leukemia 2009 23: 85-94; advance online publication, September 25, 2008; 10.1038/leu.2008.257 Abstract | Full Text The key role of stem cell factor/KIT signaling in the proliferation of blast cells from Down syndrome-related leukemia T Toki, R Kanezaki, S Adachi, H Fujino, G Xu, T Sato, K Suzuki, H Tauchi, M Endo & E Ito Leukemia 2009 23: 95-103; advance online publication, October 2, 2008; 10.1038/leu.2008.267 Abstract | Full Text Asymptomatic kidney stones in long-term survivors of childhood acute lymphoblastic leukemia S C Kaste, N A Thomas, S N Rai, K Cheon, E McCammon, R Chesney, D Jones, C-H Pui & M M Hudson Leukemia 2009 23: 104-108; advance online publication, October 2, 2008; 10.1038/leu.2008.269 Abstract | Full Text -Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia Y Hu, Y Chen, L Douglas & S Li Leukemia 2009 23: 109-116; advance online publication, September 25, 2008; 10.1038/leu.2008.262 Abstract | Full Text The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype F Dicker, H Herholz, S Schnittger, A Nakao, N Patten, L Wu, W Kern, T Haferlach & C Haferlach Leukemia 2009 23: 117-124; advance online publication, October 9, 2008; 10.1038/leu.2008.274 Abstract | Full Text Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia C Graux, M Stevens-Kroef, M Lafage, N Dastugue, C J Harrison, F Mugneret, K Bahloula, S Struski, M J Grégoire, N Nadal, E Lippert, S Taviaux, A Simons, R P Kuiper, A V Moorman, K Barber, A Bosly, L Michaux, P Vandenberghe, I Lahortiga, K De Keersmaecker, I Wlodarska, J Cools, A Hagemeijer & H A Poirel Leukemia 2009 23: 125-133; advance online publication, October 16, 2008; 10.1038/leu.2008.278 Abstract | Full Text Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia K Nebral, D Denk, A Attarbaschi, M König, G Mann, O A Haas & S Strehl Leukemia 2009 23: 134-143; advance online publication, November 20, 2008; 10.1038/leu.2008.306 Abstract | Full Text Constitutive JunB expression, associated with the JAK2 V617F mutation, stimulates proliferation of the erythroid lineage B da Costa Reis Monte-Mór, I Plo, A F da Cunha, G G L Costa, D M de Albuquerque, A Jedidi, J-L Villeval, S Badaoui, I Lorand-Metze, K B B Pagnano, S T O Saad, W Vainchenker & F F Costa Leukemia 2009 23: 144-152; advance online publication, October 9, 2008; 10.1038/leu.2008.275 Abstract | Full Text The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG) C Buske, E Hoster, M Dreyling, H Eimermacher, H Wandt, B Metzner, R Fuchs, J Bittenbring, B Woermann, K Hohloch, G Hess, W-D Ludwig, J Schimke, S Schmitz, M Kneba, M Reiser, U Graeven, W Klapper, M Unterhalt & W Hiddemann Leukemia 2009 23: 153-161; advance online publication, September 25, 2008; 10.1038/leu.2008.261 Abstract | Full Text Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors H F S Negaard, N Iversen, I M Bowitz-Lothe, P M Sandset, B Steinsvik, B Østenstad & P O Iversen Leukemia 2009 23: 162-169; advance online publication, September 18, 2008; 10.1038/leu.2008.255 Abstract | Full Text Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis T Lwin, L A Crespo, A Wu, S Dessureault, H B Shu, L C Moscinski, E Sotomayor, W S Dalton & J Tao Leukemia 2009 23: 170-177; advance online publication, October 9, 2008; 10.1038/leu.2008.266 Abstract | Full Text Letters to the Editor Top Reply to 'The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rates in hematologic malignancy patients: outcome of a pilot clinical study' by Ning et al. G Behre, S Theurich, T Weber & M Christopeit Leukemia 2009 23: 178; advance online publication, June 12, 2008; 10.1038/leu.2008.150 Abstract | Full Text Reply to "Reply to 'The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rates in hematologic malignancy patients: outcome of a pilot clinical study' by Ning H et al." by Behre et al. H Ning, F Yang, M Jiang, L Hu, K Feng, J Zhang, Z Yu, B Li, C Xu, Y Li, J Wang, J Hu, X Lou & H Chen Leukemia 2009 23: 179-180; advance online publication, June 12, 2008; 10.1038/leu.2008.151 Abstract | Full Text 5-Azacitidine has limited therapeutic activity in myelofibrosis R A Mesa, S Verstovsek, C Rivera, A Pardanani, K Hussein, T Lasho, W Wu & A Tefferi Leukemia 2009 23: 180-182; advance online publication, May 29, 2008; 10.1038/leu.2008.136 Abstract | Full Text Improving the prognostic evaluation of patients with lower risk myelodysplastic syndromes A Kuendgen, N Gattermann & U Germing Leukemia 2009 23: 182-184; advance online publication, June 12, 2008; 10.1038/leu.2008.153 Abstract | Full Text In reply to 'Improving the prognostic evaluation of patients with lower-risk myelodysplastic syndromes' by Kuendgen et al. G Garcia-Manero Leukemia 2009 23: 185; advance online publication, June 12, 2008; 10.1038/leu.2008.155 Abstract | Full Text MicroRNAs and deletion of the derivative chromosome 9 in chronic myeloid leukemia A Chaubey, S Karanti, D Rai, T Oh, S G Adhvaryu & R C T Aguiar Leukemia 2009 23: 186-188; advance online publication, June 12, 2008; 10.1038/leu.2008.154 Abstract | Full Text Transient depletion of RUNX1/RUNX1T1 by RNA interference delays tumour formation in vivo N Martinez Soria, R Tussiwand, P Ziegler, M G Manz & O Heidenreich Leukemia 2009 23: 188-190; advance online publication, June 12, 2008; 10.1038/leu.2008.157 Abstract | Full Text Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia positive acute lymphoblastic leukemia A Shimoni, M Leiba, M Schleuning, G Martineau, M Renaud, M Koren-Michowitz, E Ribakovski, P le Coutre, R Arnold, F Guilhot & A Nagler Leukemia 2009 23: 190-194; advance online publication, July 3, 2008; 10.1038/leu.2008.160 Abstract | Full Text Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparison M Mohty, H de Lavallade, J El-Cheikh, P Ladaique, C Faucher, S Fürst, N Vey, D Coso, A-M Stoppa, J-A Gastaut, C Chabannon & D Blaise Leukemia 2009 23: 194-196; advance online publication, June 26, 2008; 10.1038/leu.2008.164 Abstract | Full Text Molecular insights into the morphology of myeloproliferative neoplasms using an in situ PCR assay specific for the JAK2 mutation V617F S Gattenlohner, E Serfling, H Einsele & H K Müller-Hermelink Leukemia 2009 23: 196-199; advance online publication, June 26, 2008; 10.1038/leu.2008.168 Abstract | Full Text Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family G Cazzaniga, L Lo Nigro, I Cifola, G Milone, S Schnittger, T Haferlach, E Mirabile, F Costantino, M P Martelli, E Mastrodicasa, F Di Raimondo, F Aversa, A Biondi & B Falini Leukemia 2009 23: 199-203; advance online publication, July 3, 2008; 10.1038/leu.2008.170 Abstract | Full Text TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis D Bowen, M J Groves, A K Burnett, Y Patel, C Allen, C Green, R E Gale, R Hills & D C Linch Leukemia 2009 23: 203-206; advance online publication, July 3, 2008; 10.1038/leu.2008.173 Abstract | Full Text Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling B A Cardoso, L R Martins, C I Santos, L M Nadler, V A Boussiotis, A A Cardoso & J T Barata Leukemia 2009 23: 206-208; advance online publication, July 3, 2008; 10.1038/leu.2008.178 Abstract | Full Text Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroids G Lönnerholm, A Nordgren, B-M Frost, O G Jonsson, J Kanerva, R Nygaard, K Schmiegelow, R Larsson & E Forestier Leukemia 2009 23: 209-212; advance online publication, July 10, 2008; 10.1038/leu.2008.179 Abstract | Full Text A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease O G Best, A C Gardiner, Z A Davis, I Tracy, R E Ibbotson, A Majid, M J S Dyer & D G Oscier Leukemia 2009 23: 212-214; advance online publication, September 25, 2008; 10.1038/leu.2008.260 Abstract | Full Text Advertisement Are you looking to reach a highly-skilled market for your recruitment or classified ads? Nature Publishing Group can offer you a portfolio of prestigious journals that are targeted down to a specific sub-specialization. With over 40 specialist titles to choose from, you can attract a highly-skilled targeted audience within a number of scientific disciplines. Both print and online options are available. Contact your Naturejobs regional representative today! www.naturejobs.com   More Nature Products More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Leukemia. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2009 Nature Publishing Group